Affiliation:
1. ORDU UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, DEPARTMENT OF MEDICAL PATHOLOGY
2. ORDU UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF BASIC MEDICAL SCIENCES, DEPARTMENT OF BIOSTATISTICS
Abstract
Objective: In this study, it was aimed to evaluate the relationships between Estrogen receptor (ER), Progesterone receptor (PR), c-erbB2 (HER2), Ki67, E-Cadherin expressions, Nottingham histological grade and some clinical parameters in breast carcinomas. Materials and Methods: A total of 74 patients diagnosed with breast carcinoma (CA) in our pathology department between 2018-2019 were included in this study. Immunohistochemical preparations stained with ER, PR, HER2, Ki67 and E-Cadherin were evaluated and analyzed retrospectively. For ER and PR, ≥1% expression was considered as positive staining, and <1% was considered as negative staining. HER2 expression was scored as 0, 1, 2 and 3. Ki67 proliferation index was considered as low (<10%), intermediate (10-20%) and high risk (>20%). The data were analyzed with chi-square test. Results: HER2 score showed a statistically significant change according to ER status (p=0.010). HER2 score also showed a statistically significant change according to PR status (p=0.004). There was a significant correlation between Ki67 and histological stage (p<0.001). Conclusions: Detection of high Ki67 index in breast carcinomas is poor prognostic. Detection of ER and PR expression and no expression of HER2 are good prognostic indicators. Preanalytical and analytical processes should be followed meticulously by pathologists.
Publisher
Online Turk Saglik Bilimleri Dergisi
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference29 articles.
1. 1. Collins LC, Marotti JD, Gelber S, et al. Pathologic features and molecular phenotype by patientage in a large cohort of young women with breast cancer. Breast Cancer ResTreat. 2012;131(3):1061-1066.
2. 2. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I: The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403-410.
3. 3. Robbins P, Pinder S, de Klerk N, et al. Histological grading of breast carcinomas: A study of interobserver agreement. Hum Pathol. 1995;26(8):873-879.
4. 4. Hammond M, Hayes D, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists Guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridgedversion) Arch Pathol Lab Med. 2010;134(7):e48–e72
5. 5. Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378(9793):771–784